Abstract
Targeting of multiple genomic loci with Cas9 is limited by the need for multiple or large expression constructs. Here we show that the ability of Cpf1 to process its own CRISPR RNA (crRNA) can be used to simplify multiplexed genome editing. Using a single customized CRISPR array, we edit up to four genes in mammalian cells and three in the mouse brain, simultaneously.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Efficient genome editing in grapevine using CRISPR/LbCas12a system
Molecular Horticulture Open Access 18 October 2023
-
Programmable RNA detection with CRISPR-Cas12a
Nature Communications Open Access 05 September 2023
-
Development of the thermophilic fungus Myceliophthora thermophila into glucoamylase hyperproduction system via the metabolic engineering using improved AsCas12a variants
Microbial Cell Factories Open Access 11 August 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout


Accession codes
Change history
12 January 2017
In the version of this article initially published, in Fig. 2j, the percentage for the targets Mecp2, Nlgn3, and Drd1 should be 15.2%, not 16.9%; the same error appeared in the main text, next to last paragraph, “Our results show that ~17%...” should be “Our results show that ~15%....” In the Fig. 2 legend, KASH should be spelled out as “KASH, Klarsicht ANC1 Syne1 homology...” (not “KASH ANC1, Syne homology...”). The errors have been corrected in the HTML and PDF versions of the article.
References
Kabadi, A.M., Ousterout, D.G., Hilton, I.B. & Gersbach, C.A. Nucleic Acids Res. 42, e147 (2014).
Nissim, L., Perli, S.D., Fridkin, A., Perez-Pinera, P. & Lu, T.K. Mol. Cell 54, 698–710 (2014).
Sakuma, T., Nishikawa, A., Kume, S., Chayama, K. & Yamamoto, T. Sci. Rep. 4, 5400 (2014).
Tsai, S.Q. et al. Nat. Biotechnol. 32, 569–576 (2014).
Xie, K., Minkenberg, B. & Yang, Y. Proc. Natl. Acad. Sci. USA 112, 3570–3575 (2015).
Zetsche, B. et al. Cell 163, 759–771 (2015).
Fonfara, I., Richter, H., Bratovicčˇ, M., Rhun, A. & Charpentier, E. Nature 532, 517–521 (2016).
Yamano, T. et al. Cell 165, 949–962 (2016).
Ostlund, C. et al. J. Cell Sci. 122, 4099–4108 (2009).
Swiech, L. et al. Nat. Biotechnol. 33, 102–106 (2015).
Konermann, S. et al. Nature 500, 472–476 (2013).
Heidrich, N., Dugar, G., Vogel, J. & Sharma, C. in CRISPR (eds., M. Lundgren, E. Charpentier & P.C. Fineran) pp. 1–21 (Springer New York, 2015).
Hsu, P.D. et al. Nat. Biotechnol. 31, 827–832 (2013).
Giardine, B. et al. Genome Res. 15, 1451–1455 (2005).
Acknowledgements
We would like to thank F.A. Ran for helpful discussions and overall support, and B. Cartigny and J. van den Bogaerde for technical assistance, and the entire Zhang laboratory for support and advice. 6-His-MBP-TEV, a pET-based vector, was kindly given to us by Doug Daniels of the Broad Institute. M.H. was supported by the Human Frontiers Scientific Program. O.A.A. is supported by a Paul and Daisy Soros Fellowship and a Friends of the McGovern Institute Fellowship. J.S.G. is supported by a D.O.E. Computational Science Graduate Fellowship. E.M.D.G. is supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), of the National Institutes of Health (5T32EB1680). K.S. is supported by an NIH grant GM10407, Russian Science Foundation grant 14-14-00988, and Skoltech. J.v.d.O. is supported by Netherlands Organization for Scientific Research (NWO) through a TOP grant (714.015.001). F.Z. is supported by the NIH through NIMH (5DP1-MH100706 and 1R01-MH110049); by the New York Stem Cell, Poitras, Simons, Paul G. Allen Family, and Vallee Foundations; and by David R. Cheng, Tom Harriman, and B. Metcalfe. F.Z. is a New York Stem Cell Foundation Robertson Investigator. The authors plan to make the reagents widely available to the academic community through Addgene and to provide software tools via the Zhang lab website (http://www.genome-engineering.org/).
Author information
Authors and Affiliations
Contributions
B.Z., M.H., J.v.d.O., and F.Z. conceived this study and designed the experiments. B.Z., M.H., P.M., I.F., J.K., E.M.D., N.W., S.R.C., O.O.A., J.S.G., W.Y.W. and D.A.S. conducted the experiments. K.S., J.v.d.O., and F.Z. supervised this project. B.Z., M.H., J.v.d.O., and F.Z. wrote the manuscript with input from all authors.
Corresponding authors
Ethics declarations
Competing interests
A patent has been filed relating to the presented data. F.Z. is a founder and scientific advisor for Editas Medicine, and a scientific advisor for Horizon Discovery.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–6 and Supplementary Tables 1–5 (PDF 3028 kb)
Rights and permissions
About this article
Cite this article
Zetsche, B., Heidenreich, M., Mohanraju, P. et al. Multiplex gene editing by CRISPR–Cpf1 using a single crRNA array. Nat Biotechnol 35, 31–34 (2017). https://doi.org/10.1038/nbt.3737
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3737
This article is cited by
-
Engineered circular guide RNAs boost CRISPR/Cas12a- and CRISPR/Cas13d-based DNA and RNA editing
Genome Biology (2023)
-
Profiling the impact of the promoters on CRISPR-Cas12a system in human cells
Cellular & Molecular Biology Letters (2023)
-
Efficient genome editing in grapevine using CRISPR/LbCas12a system
Molecular Horticulture (2023)
-
Development of the thermophilic fungus Myceliophthora thermophila into glucoamylase hyperproduction system via the metabolic engineering using improved AsCas12a variants
Microbial Cell Factories (2023)
-
Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
Military Medical Research (2023)